Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors

Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors

US Patent 11559540 · Granted Jan 24, 2023

Estimated economic value: $501,305,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of determining Acute Myeloid Leukemia response to treatment with farnesyl2025
Method of determining Acute Myeloid Leukemia response to treatment with farnesyl2025
Method of determining Acute Myeloid Leukemia response to treatment with farnesyl2025
Method of determining Acute Myeloid Leukemia response to treatment with farnesyl2025
Method of predicting response to therapy by assessing tumor genetic heterogeneit2024
Non-invasive test to predict recurrence of colorectal cancer2023
Non-invasive test to predict response to therapy in colorectal cancer patients2022
Optimization of gene expression analysis using immobilized capture probes2019
Optimization of gene expression analysis using immobilized capture probes2017
Optimization of gene expression analysis using immobilized capture probes2014
Circumferential contact-less line scanning of biometric objects2014
Concurrent optimization in selection of primer and capture probe sets for nuclei2011